Welcome To The Week In Review.

  1. The First Humira Competitor Has Arrived In The U.S.

2. The Inflation Reduction Act? “I Think It’s Wonderful.”

3.  Big Pharma’s Big Lobbying

HEADS UP: Following this week’s hearing, we’ll be watching for the Senate Judiciary Committee’s upcoming markup and vote on a package of bipartisan bills that take important steps to address abuses of our patent system that inhibit innovation, block competition, and allow drug corporations to raise prices without restraint. 

Have a great weekend, everyone!